Course Date: 11th November 2009
Course Duration: 1 day
Location: Royal Society of Medicine
1 Wimpole Street
London W1G 0AE
Country: UNITED KINGDOM
Price: RSM Members
Fellow: £145 (£125 before 9 October 2009)
Associate: £115 (£100 before 9 October 2009)
Trainee: £115 (£100 before 9 October 2009)
Retired: £115 (£100 before 9 October 2009)
Student: £45 (£30 before 9 October 2009)
Non RSM Members
Doctor/Consultant/Medical Professional: £265 (£225 before 9 October 2009)
Allied Health Professional: £135 (£115 before 9 October 2009)
Nurse: £135 (£115 before 9 October 2009)
Trainee: £135 (£115 before 9 October 2009)
Student: £60 (£40 before 9 October)
Course objectives:
The programme attempts to provide a comprehensive update on the key advances in a variety of areas of research, both basic and clinical, which underpin developments in approaches to management. It aims to provide delegates with a rounded, interdisciplinary view of the underlying neurobiology, and current approached to the optimal clinical investigation an treatment of cerebral tumours; and bring together those active in basic clinical research with all clinicians involved in the management of patients with brain tumours.
Speakers include:
Professor Michael Brada
Dr Susan Short
Professor Alan Jackson
Dr Jeremy Rees
Professor Peter Collins
Professor Dr Martin J van den Bent
Dr Adam Waldman
